SUMMIT THERAPEUTICS INC
SMMTNASDAQ🏆 #673 by market capEarnings Oct 19US Equity
$15.12▲ $0.25 (+1.65%)
Market closed · at close1h—
24h▲ 1.6%
7d▲ 11.6%
14d▲ 18.2%
30d▼ 1.1%
1y▼ 41.1%
🏦Market Cap
$12.06B
Mid Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
12356.8x
Expensive
Otter Score
65
Fair
📊
Analyst Ratings
Price
$15.12
Total
21
Raised
1
Lowered
4
Avg PT
$26.00
H / L
$38 / $15
| Institution | Action | Rating | Date |
|---|---|---|---|
Stifel | Reiterated | Buy | 2026-07-24 |
Guggenheim | Reiterated | Buy | 2026-07-24 |
HC Wainwright & Co. | Reiterated | Neutral | 2026-07-23 |
Piper Sandler | Reiterated | Neutral | 2026-05-01 |
Jefferies | Downgraded | Buy → Hold | 2026-03-16 |
Citizens | Reiterated | Market Outperform | 2026-01-30 |
Barclays | Upgraded | Underweight → Equal Weight | 2025-12-17 |
JMP Securities | Reiterated | Market Outperform | 2025-10-20 |
Citigroup | Reiterated | Buy | 2025-10-20 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-09-08 |
Evercore ISI Group | Reiterated | Outperform | 2025-08-12 |
Goldman Sachs | Reiterated | Buy | 2025-05-02 |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-25 |
SunTrust Robinson Humphrey | Downgraded | Buy → Hold | 2020-11-25 |
Oppenheimer | Reiterated | Outperform | 2020-11-25 |
H.C. Wainwright | Reiterated | Buy | 2020-11-25 |
Janney Capital | Downgraded | Buy → Neutral | 2020-11-25 |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2018-06-28 |
BTIG Research | Reiterated | Buy | 2018-02-13 |
Canaccord Genuity | Reiterated | Buy | 2016-02-01 |
Needham | Reiterated | Buy | 2015-03-30 |
One row per institution, most recent rating